4502:TYO
Takeda Pharmaceutical Company
5 968,00 ¥
arrow_upward
+0,37%(+22,00) 1 d.
18. sept., 15:30:00 GMT+9 · JPY
search
Visi simboli
1 d.
5 d.
1 m.
6 m.
Š.g.
1 g.
5 g.
Maks.
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4502…
Atvērt
5 992 ¥
Augsta
6 012 ¥
Zema
5 959 ¥
Tirgus kapitalizācija
9,56 trilj.
Vid. apjoms
3,87 milj.
Apjoms
6,52 milj.
Dividende
3,35%
Ceturkšņa dividendes
50 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. sept.
Augstākā 52 ned.
6 033 ¥
Zemākā 52 ned.
4 102 ¥
Peļņa uz vienu akciju
-103 ¥
Apgrozībā esošās akcijas
784,48 milj.
Darbinieku skaits
47 tūkst.
Atvērt
5 992 ¥
Augsta
6 012 ¥
Zema
5 959 ¥
Tirgus kapitalizācija
9,56 trilj.
Vid. apjoms
3,87 milj.
Apjoms
6,52 milj.
Dividende
3,35%
Ceturkšņa dividendes
50 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 29. sept.
Augstākā 52 ned.
6 033 ¥
Zemākā 52 ned.
4 102 ¥
Peļņa uz vienu akciju
-103 ¥
Apgrozībā esošās akcijas
784,48 milj.
Darbinieku skaits
47 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
TipRanks
·
pirms 14 stundām
Dr. Reddy’s, Takeda Seal Exclusive Deal to Launch First Approved Dengue Vaccine in India’s Private Market
BusinessLine
·
pirms 20 stundām
Takeda’s Qdenga dengue vaccine to be distributed in India by Dr Reddy’s in 2027
Stock Titan
·
pirms 20 stundām
Takeda will fund healthcare projects built for climate shocks in six countries
Yahoo Finance
·
pirms 1 dienas
Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?
Profils
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Par “Takeda Pharmaceutical Company”
ĢenerāldirektorsChristophe Weber | Christophe Weber
Darbinieki47 tūkst.
Dibināšanas datums1781. gada 12. jūn.
Galvenais birojs-
Sektors-
Tīmekļa vietnetakeda.com